Stock OXFD OXFORD IMMUNOTEC GLOBAL PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Oxford Immunotec Global PLC

Equities

OXFD

GB00BGFBB958

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxford Immunotec Global : Plans to Market T Cell Immune Response Measurement Kit to COVID-19 in South Korea
Oxford Immunotec Global : Teams With Valneva on COVID-19 Vaccine Candidate Testing
Sector Update: Health Care Stocks Add to Early Rise, Supported by Biotech Companies
Sector Update: Modest Advance for Health Care Stocks Despite Larger Gains for Biotechnology Sector
PerkinElmer : to Acquire Oxford Immunotec for $591 Million
Oxford Immunotec Global : Gets Approval for T-Cell Select Reagent Kit for Tuberculosis Testing in South Korea
Oxford Immunotec Global : Signs Exclusive Distributor Agreement with Riken Genesis for SARS-CoV-2 Kit
Oxford Immunotec Global : Study Shows Protection T Cells Offer From COVID-19 in UK Keyworkers
Oxford Immunotec Global : Seeks FDA Approval for Tuberculosis Test Kit
Oxford Immunotec Global : Earnings Flash (OXFD) OXFORD IMMUNOTEC GLOBAL Posts Q3 Revenue $19.4M, vs. Street Est of $18.7M
Oxford Immunotec Global PLC Provides Revenue Guidance for the Fourth Quarter of 2020
Oxford Immunotec Global PLC Reports Earnings Results for the Third Quarter Ended September 30, 2020
Oxford Immunotec Global plc Reports Earnings Results for the Second Quarter Ended June 30, 2020
Oxford Immunotec Global PLC Not Provides Annual Revenue Guidance for the Year 2020
Oxford Immunotec Global PLC Provides Revenue Guidance for the Third and Fourth Quarter of 2020
Oxford Immunotec Global plc Announces Revenue Guidance for Second Quarter
Oxford Immunotec Global PLC Revised Revenue Guidance for the First Quarter of 2020; Withdraws Revenues Guidance for the Full Year of 2020
Oxford Immunotec Global plc Provides Earnings Guidance for the Full Year 2020
Oxford Immunotec Global PLC Revises Revenue Guidance for the Full Year 2019 and Provides Revenue Guidance for the Fourth Quarter of 2019
Oxford Immunotec Global PLC Provides Revenue Guidance for the Third Quarter and Full Year of Fiscal Year 2019
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OXFD Stock
  4. News Oxford Immunotec Global PLC
  5. Other languages